Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Bought by Gilman Hill Asset Management LLC

Gilman Hill Asset Management LLC lifted its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Rating) by 24.0% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 477,854 shares of the real estate investment trust’s stock after buying an additional 92,540 shares during the period. Sabra Health Care REIT makes up 1.4% of Gilman Hill Asset Management LLC’s holdings, making the stock its 24th largest position. Gilman Hill Asset Management LLC owned about 0.21% of Sabra Health Care REIT worth $6,676,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in Sabra Health Care REIT by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 36,317,289 shares of the real estate investment trust’s stock valued at $540,765,000 after acquiring an additional 859,548 shares in the last quarter. Principal Financial Group Inc. grew its holdings in shares of Sabra Health Care REIT by 1.5% in the 1st quarter. Principal Financial Group Inc. now owns 17,124,112 shares of the real estate investment trust’s stock valued at $254,977,000 after acquiring an additional 256,869 shares in the last quarter. State Street Corp grew its holdings in Sabra Health Care REIT by 18.1% during the first quarter. State Street Corp now owns 12,035,766 shares of the real estate investment trust’s stock worth $179,213,000 after purchasing an additional 1,840,939 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Sabra Health Care REIT by 7.5% during the first quarter. Goldman Sachs Group Inc. now owns 5,486,951 shares of the real estate investment trust’s stock worth $81,701,000 after acquiring an additional 384,092 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Sabra Health Care REIT by 8.5% in the fourth quarter. Geode Capital Management LLC now owns 4,886,869 shares of the real estate investment trust’s stock valued at $66,168,000 after buying an additional 383,968 shares in the last quarter. 87.67% of the stock is owned by institutional investors and hedge funds.

Sabra Health Care REIT Price Performance

Shares of NASDAQ:SBRA traded down $0.38 during midday trading on Friday, reaching $13.24. 47,890 shares of the company were exchanged, compared to its average volume of 2,015,273. The company has a current ratio of 3.97, a quick ratio of 3.97 and a debt-to-equity ratio of 0.75. The business’s fifty day moving average is $15.09 and its two-hundred day moving average is $14.14. Sabra Health Care REIT, Inc. has a one year low of $11.44 and a one year high of $16.60. The stock has a market cap of $3.06 billion, a PE ratio of 71.69 and a beta of 1.31.

Sabra Health Care REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 31st. Shareholders of record on Wednesday, August 17th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Tuesday, August 16th. This represents a $1.20 annualized dividend and a yield of 9.06%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 631.61%.

Analyst Ratings Changes

SBRA has been the topic of several analyst reports. Capital One Financial began coverage on shares of Sabra Health Care REIT in a research note on Friday, June 3rd. They issued an “equal weight” rating and a $15.50 price objective on the stock. Jefferies Financial Group cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and lowered their price objective for the company from $15.00 to $14.00 in a research report on Thursday, June 30th. Citigroup lifted their target price on shares of Sabra Health Care REIT to $15.50 in a research note on Monday, August 22nd. Finally, Barclays boosted their price objective on shares of Sabra Health Care REIT to $15.00 in a report on Tuesday, August 9th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $15.91.

Sabra Health Care REIT Profile

(Get Rating)

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing – Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture.

See Also

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Rating).

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.